311 related articles for article (PubMed ID: 19439169)
1. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery.
Hu L; Jia Y; WenDing
Pharmazie; 2010 Aug; 65(8):585-7. PubMed ID: 20824958
[TBL] [Abstract][Full Text] [Related]
3. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
4. A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy.
Liu CW; Wu YT; Lin KJ; Yu TJ; Kuo YL; Chang LC
Molecules; 2016 Jun; 21(6):. PubMed ID: 27258243
[TBL] [Abstract][Full Text] [Related]
5. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
7. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
10. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
11. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
13. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Lo YL; Liu Y; Tsai JC
Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
[TBL] [Abstract][Full Text] [Related]
14. [Fundamental studies on intravesical instillation of 4'-epi-adriamycin for the treatment of bladder cancer].
Tsushima T
Hinyokika Kiyo; 1985 Nov; 31(11):1945-56. PubMed ID: 3867286
[TBL] [Abstract][Full Text] [Related]
15. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
[TBL] [Abstract][Full Text] [Related]
18. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer.
Elkashef A; Barakat N; Khater SM; Awadalla A; Belal F; El-Assmy AM; Sheir KZ; Shokeir AA
BJU Int; 2021 Jan; 127(1):80-89. PubMed ID: 32654305
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
